Role of real-world evidence in informing cancer care: lessons from colorectal cancer

被引:21
作者
Batra, A. [1 ,2 ]
Cheung, W. Y. [1 ,2 ]
机构
[1] Univ Calgary, Cumming Sch Med, Dept Oncol, Calgary, AB, Canada
[2] Tom Baker Canc Clin, Sect Med Oncol, Calgary, AB, Canada
关键词
Real-world evidence; colorectal cancer; III COLON-CANCER; ADJUVANT CHEMOTHERAPY; ELDERLY-PATIENTS; STAGE-II; RECTAL-CANCER; IMPACT; OXALIPLATIN; SURVIVAL; OUTCOMES; FLUOROURACIL;
D O I
10.3747/co.26.5625
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The term "real-world evidence" (RWE) describes the analysis of data that are collected beyond the context of clinical trials. The use and application of RWE have become increasingly common and relevant, especially in oncology, because there is growing recognition that randomized controlled trials (RCTS) might not be sufficiently representative of the entire patient population that is affected by cancer, and that specific clinical research questions might be best addressed by real-world data. In this brief review, our main aim is to highlight the role of RWE in informing cancer care, particularly focusing on specific examples from colorectal cancer. Our hope is to illustrate the ways in which RWE can complement RCTS in improving the understanding of cancer management and how RWE can facilitate cancer treatment decisions for real-world patients encountered in routine clinical care.
引用
收藏
页码:S53 / S56
页数:4
相关论文
共 26 条
  • [1] Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
    Andre, T
    Boni, C
    Mounedji-Boudiaf, L
    Navarro, M
    Tabernero, J
    Hickish, T
    Topham, C
    Zaninelli, M
    Clingan, P
    Bridgewater, J
    Tabah-Fisch, I
    de Gramont, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) : 2343 - 2351
  • [2] Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer A Systematic Review and Meta-analysis
    Biagi, James J.
    Raphael, Michael J.
    Mackillop, William J.
    Kong, Weidong
    King, Will D.
    Booth, Christopher M.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (22): : 2335 - 2342
  • [3] Population-Based Patterns and Factors Associated With Underuse of Palliative Systemic Therapy in Elderly Patients With Metastatic Colon Cancer
    Chan, Matthew
    Hugh-Yeun, Kiara
    Gresham, Gillian
    Speers, Caroline H.
    Kennecke, Hagen F.
    Cheung, Winson Y.
    [J]. CLINICAL COLORECTAL CANCER, 2017, 16 (02) : 147 - 153
  • [4] The economic impact of the transition from branded to generic oncology drugs
    Cheung, W. Y.
    Kornelsen, E. A.
    Mittmann, N.
    Leighl, N. B.
    Cheung, M.
    Chan, K. K.
    Bradbury, P. A.
    Ng, R. C. H.
    Chen, B. E.
    Ding, K.
    Pater, J. L.
    Tu, D.
    Hay, A. E.
    [J]. CURRENT ONCOLOGY, 2019, 26 (02) : 89 - 93
  • [5] Etiology of Delays in the Initiation of Adjuvant Chemotherapy and Their Impact on Outcomes for Stage II and III Rectal Cancer
    Cheung, Winson Y.
    Neville, Bridget A.
    Earle, Craig C.
    [J]. DISEASES OF THE COLON & RECTUM, 2009, 52 (06) : 1054 - 1063
  • [6] Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical Trials
    Duma, Narjust
    Kothadia, Sejal M.
    Azam, Tariq U.
    Yadav, Siddhartha
    Paludo, Jonas
    Aguilera, Jesus Vera
    Velez, Miguel Gonzalez
    Halfdanarson, Thorvardur Ragnar
    Molina, Julian R.
    Hubbard, Joleen M.
    Go, Ronald S.
    Mansfield, Aaron S.
    Adjei, Alex A.
    [J]. ONCOLOGIST, 2019, 24 (01) : 96 - 102
  • [7] Older cancer patients in cancer clinical trials are underrepresented. Systematic literature review of almost 5000 meta- and pooled analyses of phase III randomized trials of survival from breast, prostate and lung cancer
    Dunn, Cita
    Wilson, Andrew
    Sitas, Freddy
    [J]. CANCER EPIDEMIOLOGY, 2017, 51 : 113 - 117
  • [8] When and How Can Real World Data Analyses Substitute for Randomized Controlled Trials?
    Franklin, Jessica M.
    Schneeweiss, Sebastian
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (06) : 924 - 933
  • [9] The use of chemotherapy in older patients with stage II and III colon cancer: Variation by age and era of diagnosis
    Green, Susan L.
    Dawe, David E.
    Nugent, Zoann
    Cheung, Winson Y.
    Czaykowski, Piotr M.
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2019, 10 (01) : 132 - 137
  • [10] Time to Adjuvant Chemotherapy and Survival Outcomes Among Patients With Stage 2 to 3 Rectal Cancer Treated With Preoperative Chemoradiation
    Gresham, Gillian
    Cheung, Winson Y.
    Speers, Caroline
    Woods, Ryan
    Kennecke, Hagen
    [J]. CLINICAL COLORECTAL CANCER, 2015, 14 (01) : 41 - 45